Thanks! You've successfully subscribed to the BONEZONE®/OMTEC® Monthly eNewsletter!

Please take a moment to tell us more about yourself and help us keep unwanted emails out of your inbox.

Choose one or more mailing lists:
BONEZONE/OMTEC Monthly eNewsletter
OMTEC Conference Updates
Advertising/Sponsorship Opportunities
Exhibiting Opportunities
* Indicates a required field.

Rapid Fire | Implant Infection Prevention

Wednesday, June 14
10:00 am - 11:00 am
Tech Center

Related Resources:
Infection Prevention Spurs New R&D Ideas
Silver Ions Found Effective in Fighting Infections while Forming Bone


Robin Büscher,

Director R&D for
Global Funding
and Research 
Stryker Trauma

Matthew Dietz, M.D.

Orthopaedic Surgeon
West Virginia University

Thomas J. Webster, Ph.D.
Chair and Professor of Chemical Engineering
Northeastern University



Post-surgical infection control is a top priority in the reduction of complications, revisions and costs. It’s a topic of importance along the spectrum of development, from the surgeon, to the research level, to start-up, through to the industry’s largest companies. This rapid fire brings together the surgeon, research and device company perspective on the current state and future of infection prevention in orthopaedics.

While many technological approaches are proposed to reduce bacterial colonization on orthopaedic implants, only a few solutions have made it to market. Dr. Büescher’s presentation will provide a brief overview of various antimicrobial strategies and will discuss the risks, hurdles and efforts for a device manufacturer to bring those technologies to the market.

Dr. Dietz’s presentation will focus on the devastating impact that implant-related infections can have on a patient, surgeon and healthcare system. He will highlight effective steps that have been taken to reduce the incidence of infection, and focus on the challenges that we continue to face in the prevention and treatment of implant-related infections.

Dr. Webster will show how modifying only the nanofeatures on material surfaces without changing surface chemistry, it is possible to control cell responses that decrease infection, increase tissue growth and decrease inflammation. This strategy also accelerates FDA approval and commercialization efforts by altering nanoscale features in chemistries already approved by the FDA. This talk will highlight some of the advancements and emphasize current nanomaterials approved by the FDA for human implantation.  


Attendee Takeaways

  1. Impact of surgical site infection on patients and healthcare system
  2. Current measures to reduce surgical infection
  3. Current and future technologies being developed to address surgical infections


Robin Büscher, Dr.,-Ing., is Director R&D for Global Funding and Research within Stryker’s trauma division. He spent the last 12 years in various leading R&D positions within Stryker, managing global development teams for trauma, extremities and craniomaxillofacial products and technologies. 

Matthew Dietz, M.D., is an Assistant Professor at West Virginia University School of Medicine, Department of Orthopaedics. His practice focuses on routine and complicated primary hip and knee arthroplasties along with complex revisions. In his role as a clinician scientist, his research focus is on implant-associated infections, the biophysical disruption of biofilms in total joint arthroplasty and the care surrounding patients affected by prosthetic joint infections. Dr. Dietz is a member of American Association of Hip and Knee Surgeons, Orthopaedic Research Society and a Fellow in the American Association of Orthopaedic Surgeons.

Thomas J. Webster, Ph.D., is Department Chair of Chemical Engineering at Northeastern University. He also serves as Director of Nanomedicine Laboratories and has completed extensive studies on the use of nanophase materials in medicine. His recent honors include: Zheijang 1000 Talent Program, 2016; International Materials Research Chinese Academy of Science Lee-Hsun Lecture Award; and 2016 International College of Fellows, Biomaterials Science and Engineering. He is also the 1st Past President of the U.S. Society For Biomaterials. He holds a B.S. in chemical engineering from the University of Pittsburgh, a Master’s and Ph.D. in Biomedical Engineering from Rensselaer Polytechnic Institute.

Helpful links: New Trauma Technologies Emerge to Treat Infections | Silver Ions Found Effective in Fighting Infections while Forming Bone